July 2022 FDA Recall Pantoprazole Sodium by Sun Pharmaceutical Industries Inc
D-0068-2023 - Discoloration

This Class II drug recall was voluntarily initiated by Sun Pharmaceutical Industries Inc on July 25, 2022 for the product Pantoprazole Sodium. The FDA reported the reason for recall as discoloration. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0068-2023

Reason for Recall
Discoloration
Initiated
07-25-2022
Reported
11-30-2022
Quantity
14, 064 (30 sachets in a carton)

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
SUN PHARMACEUTICAL INDUSTRIES INC
Nationwide in the USA.
Pantoprazole Sodium for Delayed-Release Oral Suspension*40 mg* suspension in apple juice or applesauce only Each packet contains 40 mg pantoprazole equivalent to 45.1 mg of pantoprazole sodium USP (sesquihydrate), Rx Only, distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, manufactured by: Sun Pharmaceutical Industries Limited Mohali, INDIA, NDC 62756-071-60

Batch or Lot Expiration Information

Lot# : MHC1317A, Exp 07/2023